2,247 results on '"Dorian, Paul"'
Search Results
2. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
3. Centre-Specific Variation in Atrial Fibrillation Ablation-Treatment Rates in a Universal Single-Payer Healthcare System
4. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation
5. The impact of alternate defibrillation strategies on shock-refractory and recurrent ventricular fibrillation: A secondary analysis of the DOSE VF cluster randomized controlled trial
6. ICD Implantation Rates in Cardiac Arrest Survivors in Canada
7. Incidence of Hospital Admission of Out-of-Hospital Cardiac Arrest Patients, and Their Outcomes, in Canada, 2013-2017
8. The impact of double sequential shock timing on outcomes during refractory out-of-hospital cardiac arrest
9. Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
10. Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms
11. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
12. The Effect of Time to Treatment With Antiarrhythmic Drugs on Survival and Neurological Outcomes in Shock Refractory Out-of-Hospital Cardiac Arrest
13. An In-Silico model for evaluating the directional shock vectors in terminating and modulating rotors
14. Responding to Cardiac Arrest in the Community in the Digital Age
15. Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study
16. Anti-Arrhythmic Drugs
17. Immediate Versus Delayed Angiography after Out-of-Hospital Cardiac Arrest Without ST Segment Elevation
18. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation
19. Exercise‐Dependent Modulation of Immunological Response Pathways in Endurance Athletes With and Without Atrial Fibrillation
20. Atrial fibrillation in middle-aged athletes: Impact on left atrial, ventricular and exercise performance
21. Accuracy of Wearable Heart Rate Monitors During Exercise in Sinus Rhythm and Atrial Fibrillation
22. COVID-19–Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group
23. Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation
24. A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope
25. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?
26. Abstract 14016: Marked Geographic Variation in Atrial Fibrillation Ablation Rates in a Universal Single Payer Health Care System
27. Cultural Perceptions of Academic Honesty in the United Arab Emirates
28. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
29. Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis
30. Field Implementation of Remote Ischemic Conditioning in ST-Segment–Elevation Myocardial Infarction: The FIRST Study
31. The Role of Quality of Life Indices in Patient-Centred Management of Arrhythmia
32. Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia
33. Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
34. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
35. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
36. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial
37. Objective And Subjective Assessments Of Exercise Burden In Masters Athletes Are Poorly Correlated
38. Multi-centre implementation of an Educational program to improve the Cardiac Arrest diagnostic accuracy of ambulance Telecommunicators and survival outcomes for sudden cardiac arrest victims: the EduCATe study design and methodology
39. Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators
40. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices
41. Canadian Cardiovascular Society Cardiovascular Screening of Competitive Athletes: The Utility of the Screening Electrocardiogram to Predict Sudden Cardiac Death
42. Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design
43. Health care utilization prior to out-of-hospital cardiac arrest: A population-based study
44. Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS2 Score: Insights From the BRAIN-AF Trial
45. Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis
46. Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience
47. Temporal trends in sudden cardiac death in Ontario, Canada
48. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation
49. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes
50. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.